Advanced deadly forms of melanoma are resistant to current therapies. Better understanding of the regulatory circuits of melanoma development helps to identify novel therapeutic targets.
Interferon regulatory factor 4 (IRF4) is a transcriptional regulator with a critical role in lymphocyte development and function. Recent evidence shows that it plays a major role in lymphoma and multiple myeloma.
Further details: New molecular targets for melanoma treatment